Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004162121 | SCV003645022 | uncertain significance | not specified | 2022-09-06 | criteria provided, single submitter | clinical testing | The c.311C>T (p.S104L) alteration is located in exon 2 (coding exon 2) of the NPC1L1 gene. This alteration results from a C to T substitution at nucleotide position 311, causing the serine (S) at amino acid position 104 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |